Nanobiotix ADRs Jump Over 50% After Agreement With J&J’s Janssen Pharmaceutical
Nanobiotix ADRs Jump Over 50% After Agreement With J&J's Janssen Pharmaceutical InvestopediaJ&J capitalizes on Nanobiotix cash crunch to capture late-phase cancer candidate for $30M upfront FierceBiotechNANOBIOTIX Announces…